This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Seijffers, R. Articles by Ferber, S. Search for Related Content PubMed PubMed Citation Articles by Seijffers, R. Articles by Ferber, S.

Increase in PDX-1 Levels Suppresses Insulin Gene Expression in RIN 1046–38 Cells¹

Endocrine Institute, Sheba Medical Center (R.S., O.B-D., Y.C., A.K., M.B., S.F.), Tel-Hashomer 52621; Tel-Aviv University Sackler School of Medicine (R.S., O.B.-D., A.K., M.B.), Tel-Aviv; and Bar-Ilan University (Y.C.), Ramat-Gan 52900, Israel; and the Departments of Biochemistry and Internal Medicine, University of Texas Southwestern Medical Center (C.B.N.), Dallas, Texas 75235

Address all correspondence and requests for reprints to: Sarah Ferber, Ph.D., Endocrine Institute, Sheba Medical Center, Tel-Hashomer, Israel. E-mail: berezin{at}post.tau.ac.il

RIN1046–38 cells (RIN-38) exhibit a passage-dependent reduction in both basal and glucose-regulated insulin secretion, accompanied by decreased insulin content. In an attempt to explain the mechanism of the gradual decrease in insulin production in cultured cells, we analyzed the insulin promoter activity and the levels of an important trans-activator of the insulin gene, PDX-1, as a function of aging in culture. We demonstrate that the decrease in insulin content and secretion is reflected in decreased promoter activity and is associated with a decrease in E47 and BETA2 nuclear factors, but with a paradoxical 3-fold increase in PDX-1 protein levels. To dissect the effect of increased PDX-1 from the decrease in the additional transcription factors on insulin promoter activity, we overexpressed PDX-1 protein in low passage RIN-38 cells by recombinant adenovirus technology. PDX-1 overexpression did not reduce E47 and BETA2 levels, but was sufficient to suppress rat insulin promoter activity in a dose-dependent manner. The fact that PDX-1 levels participate in trans-activation of insulin promoter activity was demonstrated in HIT-T15 cells. Treating HIT-T15 cells with 1–2 multiplicity of infection of AdCMV-PDX-1 increased rat insulin promoter activity, whereas higher doses repressed insulin promoter activity in these cells as in RIN-38 cells. Our data demonstrate that PDX-1 regulates transcription of the insulin gene in a dose-dependent manner. Depending on its nuclear dosage and the levels of additional cooperating transcription factors, PDX-1 may act as an activator or a repressor of insulin gene expression, such that low as well as high doses may be deleterious to insulin production.

This article has been cited by other articles:

				J. L. Volinic, J. H. Lee, K. Eto, V. Kaur, and M. K. Thomas Overexpression of the Coactivator Bridge-1 Results in Insulin Deficiency and Diabetes Mol. Endocrinol., January 1, 2006; 20(1): 167 - 182. [Abstract] [Full Text] [PDF]

				D. K. Hagman, L. B. Hays, S. D. Parazzoli, and V. Poitout{paragraph} Palmitate Inhibits Insulin Gene Expression by Altering PDX-1 Nuclear Localization and Reducing MafA Expression in Isolated Rat Islets of Langerhans J. Biol. Chem., September 16, 2005; 280(37): 32413 - 32418. [Abstract] [Full Text] [PDF]

				T. Sapir, K. Shternhall, I. Meivar-Levy, T. Blumenfeld, H. Cohen, E. Skutelsky, S. Eventov-Friedman, I. Barshack, I. Goldberg, S. Pri-Chen, et al. From the Cover: Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells PNAS, May 31, 2005; 102(22): 7964 - 7969. [Abstract] [Full Text] [PDF]

				M. F. Pino, D. Z. Ye, K. D. Linning, C. D. Green, B. Wicksteed, V. Poitout, and L. K. Olson Elevated Glucose Attenuates Human Insulin Gene Promoter Activity in INS-1 Pancreatic {beta}-Cells via Reduced Nuclear Factor Binding to the A5/Core and Z Element Mol. Endocrinol., May 1, 2005; 19(5): 1343 - 1360. [Abstract] [Full Text] [PDF]

				I. Ber, K. Shternhall, S. Perl, Z. Ohanuna, I. Goldberg, I. Barshack, L. Benvenisti-Zarum, I. Meivar-Levy, and S. Ferber Functional, Persistent, and Extended Liver to Pancreas Transdifferentiation J. Biol. Chem., August 22, 2003; 278(34): 31950 - 31957. [Abstract] [Full Text] [PDF]

				G. Leibowitz, S. Ferber, A. Apelqvist, H. Edlund, D. J. Gross, E. Cerasi, D. Melloul, and N. Kaiser IPF1/PDX1 Deficiency and {beta}-Cell Dysfunction in Psammomys obesus, an Animal With Type 2 Diabetes Diabetes, August 1, 2001; 50(8): 1799 - 1806. [Abstract] [Full Text] [PDF]

				L. B. Lester, M. C. Faux, J. B. Nauert, and J. D. Scott Targeted Protein Kinase A and PP-2B Regulate Insulin Secretion through Reversible Phosphorylation Endocrinology, March 1, 2001; 142(3): 1218 - 1227. [Abstract] [Full Text] [PDF]

				H. Wang, P. Maechler, B. Ritz-Laser, K. A. Hagenfeldt, H. Ishihara, J. Philippe, and C. B. Wollheim Pdx1 Level Defines Pancreatic Gene Expression Pattern and Cell Lineage Differentiation J. Biol. Chem., June 29, 2001; 276(27): 25279 - 25286. [Abstract] [Full Text] [PDF]

				S. Vaulont, M. Vasseur-Cognet, and A. Kahn Glucose Regulation of Gene Transcription J. Biol. Chem., October 6, 2000; 275(41): 31555 - 31558. [Full Text] [PDF]